CN112641098A - 一种具有调理肠胃腹泻功能的阿拉伯胶组合物 - Google Patents
一种具有调理肠胃腹泻功能的阿拉伯胶组合物 Download PDFInfo
- Publication number
- CN112641098A CN112641098A CN202011481205.8A CN202011481205A CN112641098A CN 112641098 A CN112641098 A CN 112641098A CN 202011481205 A CN202011481205 A CN 202011481205A CN 112641098 A CN112641098 A CN 112641098A
- Authority
- CN
- China
- Prior art keywords
- diarrhea
- function
- oligosaccharide
- arabic gum
- freeze
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 26
- 235000010489 acacia gum Nutrition 0.000 title claims abstract description 18
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 title claims abstract description 11
- 230000002496 gastric effect Effects 0.000 title claims abstract description 10
- 239000001785 acacia senegal l. willd gum Substances 0.000 title claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 12
- 235000019202 steviosides Nutrition 0.000 claims abstract description 11
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 8
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 8
- 229940013618 stevioside Drugs 0.000 claims abstract description 8
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 7
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 7
- 239000008103 glucose Substances 0.000 claims abstract description 7
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 6
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 4
- 229920000084 Gum arabic Polymers 0.000 claims description 9
- 239000000205 acacia gum Substances 0.000 claims description 9
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 7
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 7
- 240000009088 Fragaria x ananassa Species 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 abstract description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 3
- 210000000936 intestine Anatomy 0.000 abstract description 3
- 239000011707 mineral Substances 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 230000006870 function Effects 0.000 description 8
- 208000004998 Abdominal Pain Diseases 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241000220223 Fragaria Species 0.000 description 6
- 230000013872 defecation Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- -1 sucrose triose group oligosaccharides Chemical class 0.000 description 4
- 244000215068 Acacia senegal Species 0.000 description 3
- 239000004383 Steviol glycoside Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 229930182488 steviol glycoside Natural products 0.000 description 3
- 235000019411 steviol glycoside Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- 206010014418 Electrolyte imbalance Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 208000026775 severe diarrhea Diseases 0.000 description 2
- 150000008144 steviol glycosides Chemical class 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003903 intestinal lesions Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种具有调理肠胃腹泻功能的阿拉伯胶组合,其包括阿拉伯胶、低聚果糖、低聚半乳糖、葡萄糖甜菊糖苷、冻干粉。本发明组合物食用安全性高,营养丰富,无副作用,口感佳,能够容易被患者消化吸收,一方面为患者补充天然矿物质,另一方面还可对肠胃进行调理,防治腹泻,且本发明可促进双歧杆菌增殖,能够保持身体里有益菌与有害菌的平衡,调整微生态失调,进而对肠胃进行调理。
Description
技术领域
本发明涉及保健品技术领域,尤其涉及一种具有调理肠胃腹泻功能的阿拉伯胶组合物。
背景技术
腹泻是一种常见的多发病,它对健康的最大损害是导致营养不良。腹泻时,丢失的不仅是水和电解质,而且丢失大量的蛋白质和其它的营养物质,严重的腹泻会因电解质紊乱导致死亡。而慢性肠炎腹泻更是一种常见的顽固性疾病,通常久治不愈,腹泻与人体的生活习惯有很大关系,比如饮食不规律、排便习惯不良、肠道病变等。目前治疗肠道疾病还是以药物为主,然而这些药物的使用往往会导致肠道神经应激性的改变,长期来看会导致对药物形成依赖。除了西药外,目前比较常见的还有中药理疗和生物反馈治疗,然而目前逐渐显露出来的弊端也比较明显,比如机体电解质失衡、炎症反应、微生态失衡等。
发明内容
因此,基于以上背景,本发明提供了一种调理效果佳,无副作用具有调理肠胃腹泻功能的阿拉伯胶组合物。
本发明的技术方案为:
一种具有调理肠胃腹泻功能的阿拉伯胶组合,其包括下组分:
阿拉伯胶、低聚果糖、低聚半乳糖、葡萄糖甜菊糖苷、冻干粉。
进一步地,其包括以下重量份的组分:
阿拉伯胶60%、低聚果糖20%、低聚半乳糖10%,其余10%组分包括葡萄糖甜菊糖苷和冻干粉。
进一步地,所述冻干粉为草莓冻干粉。
其中,所复配组分的功效为:
阿拉伯胶:阿拉伯胶是一种水溶性的多糖物质,属水合胶体一族,是一种含有钙,镁,钾等多种阳离子的弱酸性多糖大分子.天然胶块以类似椭圆形存在,颜色为略透明的琥珀色,其具有着复杂的分子结构,其中主要成分包括:D-半乳糖44%,L-阿拉伯糖24%,D-葡萄糖醛酸14.5%,L-鼠李糖13%,4-O-甲基-O-葡萄糖醛酸1.5%。
低聚果糖:又称寡果糖或蔗糖三糖族低聚糖。低聚果糖通常食用的很多水果、蔬菜中均存在。低聚果糖拥有保健功能确切和食品配料优良的双重品格。以具有低热量、无龋齿、促进双歧杆菌增殖、降血糖,改善血清脂质,促进微量元素吸收等优良生理功能。
葡萄糖甜菊糖苷:又称酶转苷甜菊糖苷,或酶改质甜菊糖苷。是以甜叶菊叶为原料,经酶法对在甜叶菊叶中提取的甜菊糖苷进行葡萄糖基化,然后经蒸发浓缩、喷雾干燥而得的食品添加剂葡萄糖基甜菊糖苷,其用于食品添加可增加食品甜度。
草莓冻干粉:最大限度地保持了原新鲜草莓的色、香、味,及营养成分,具有新鲜草莓的营养价值。
采用上述技术方案,具有的有益效果如下:
本发明组配合理,其组分能够协调作用,充分发挥功效作用,实现调理肠胃、防治腹泻的功效。其中本产品富含了天然矿物质钙,镁,钾对于补充人体的矿物质起到了显著的效果和积极的作用。
且本发明组合物食用安全性高,营养丰富,无副作用,口感佳,能够容易被患者消化吸收,一方面为患者提供营养,另一方面还可对肠胃进行调理,防治腹泻,且本发明可促进双歧杆菌增殖,能够保持身体里有益菌与有害菌的平衡,调整微生态失调,进而对肠胃进行调理。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例中的示范,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1:一种具有调理肠胃腹泻功能的阿拉伯胶组合,其包括以下重量份组分:
阿拉伯胶、低聚果糖、低聚半乳糖、葡萄糖甜菊糖苷、草莓冻干粉。
其使用方式为:按量称取上述各组分,将上述粉剂的各组分混合后制成颗粒型后,进行分装成15g的小袋进行备用;在服用时,只需要将小袋中的颗粒用温开水进行冲泡,服下即可。
本实施例中的阿拉伯胶组合物所含物质组分检测,见表一,检测单位为山东中质华检测试检验有限公司。
表一:检测结果
检测项目 | 技术要求 | 检测方法 | 检测结果 | 单位 |
能量 | / | GB 28050-2011 | 1162 | KJ/100g |
蛋白质 | / | GB 5009.5-2016等一法 | 1.0 | g/100g |
脂肪 | / | GB 5009.5-2016等一法 | 0.7 | g/100g |
碳水化合物 | / | GB 28050-2011 | 44.2 | g/100g |
膳食纤维 | / | GB 5009.88-2014 | 45.9 | g/100g |
钠 | / | GB 5009.91-2017第二法 | 4(≤5) | mg/100g |
案例1:郭某,男,11岁。其在某天中午放学后,感觉肚子稍微有些疼痛,出现腹泻,其大便较稀,不成型;未采取措施,下午上课时,其肚子疼痛加剧,在下午5点左右时,出现腹泻两次,大便均是较稀,不成型。
其按照实施例1的方式用200毫升60度的水,进行冲泡后服用,20分钟后,肚子疼痛感减轻,且半小时后,肚子有气体排出,肚子疼痛感小时,且未再出现腹泻。
案例2:李某,女,33岁。其某天出现腹泻严重,腹痛严重,其排便间隔时间短,且排便时间长,大便较稀,不成型。
其按照实施例1的使用方式每日上午用温水冲服1袋,1天后,腹痛减轻,排便次数明显减少,排便间隔时间长;3天后,腹痛感消失,正常排便,且大便成型。
案例3:马某,男,28岁。其某天肚子出现胀气,有疼痛感,且出现腹泻,大便不成型。
其按照实施例1的使用方式用温水冲服1袋,20分钟后,肚子疼痛感消失,且其腹泻出现停止。
案例4:张某,男,31岁。其无法使用凉食,每次食用后,均出现腹泻。
其按照实施例1的使用方式在每日饭前用温水冲服1袋,3日后,其在食用凉食后,未出现腹泻。
案例5:赵某,男,3岁。其在每次饮酒后,都会出现腹泻。
其按照实施例1的使用方式在每次饮酒前用温水冲服1袋,在饮酒后,均未再出现腹泻。
以上对本发明及其实施方式进行了描述,这种描述没有限制性,实施例所示的也只是本发明的实施方式之一,实际的结构并不局限于此。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护范围。
Claims (3)
1.一种具有调理肠胃腹泻功能的阿拉伯胶组合物,其特征在于,其包括以下组分:
阿拉伯胶、低聚果糖、低聚半乳糖、葡萄糖甜菊糖苷、冻干粉。
2.根据权利要求1所述的一种具有调理肠胃腹泻功能的阿拉伯胶组合物,其特征在于,其包括以下重量份的组分:
阿拉伯胶60%、低聚果糖20%、低聚半乳糖10%,其余10%组分包括葡萄糖甜菊糖苷和冻干粉。
3.根据权利要求1所述的一种具有调理肠胃腹泻功能的阿拉伯胶组合物,其特征在于,所述冻干粉为草莓冻干粉。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011481205.8A CN112641098A (zh) | 2020-12-15 | 2020-12-15 | 一种具有调理肠胃腹泻功能的阿拉伯胶组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011481205.8A CN112641098A (zh) | 2020-12-15 | 2020-12-15 | 一种具有调理肠胃腹泻功能的阿拉伯胶组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112641098A true CN112641098A (zh) | 2021-04-13 |
Family
ID=75354148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011481205.8A Pending CN112641098A (zh) | 2020-12-15 | 2020-12-15 | 一种具有调理肠胃腹泻功能的阿拉伯胶组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112641098A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1731938A (zh) * | 2002-12-12 | 2006-02-08 | 诺瓦提斯公司 | 益生元组合物 |
CN108289493A (zh) * | 2015-12-31 | 2018-07-17 | 雀巢产品技术援助有限公司 | 用于改善口感的组合物 |
CN110214948A (zh) * | 2019-07-07 | 2019-09-10 | 广州正广生物科技有限公司 | 一种具有润肠通便功能的组合物及其制备方法 |
CN111631264A (zh) * | 2020-04-22 | 2020-09-08 | 奇佳宜(北京)健康科技有限责任公司 | 一种高蛋白高膳食纤维果蔬代餐奶昔固体饮料及其应用 |
-
2020
- 2020-12-15 CN CN202011481205.8A patent/CN112641098A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1731938A (zh) * | 2002-12-12 | 2006-02-08 | 诺瓦提斯公司 | 益生元组合物 |
CN108289493A (zh) * | 2015-12-31 | 2018-07-17 | 雀巢产品技术援助有限公司 | 用于改善口感的组合物 |
CN110214948A (zh) * | 2019-07-07 | 2019-09-10 | 广州正广生物科技有限公司 | 一种具有润肠通便功能的组合物及其制备方法 |
CN111631264A (zh) * | 2020-04-22 | 2020-09-08 | 奇佳宜(北京)健康科技有限责任公司 | 一种高蛋白高膳食纤维果蔬代餐奶昔固体饮料及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2473209C (en) | Stimulation of the immune system with polydextrose | |
CN106954847A (zh) | 具有润肠通便功能的酵素益生菌组合物、应用及加工制剂 | |
JP2016172761A (ja) | 整腸及び/又は便通改善のための組成物 | |
CN112704237A (zh) | 一种植物肽减脂组合物及其食用方法 | |
JP2006512298A (ja) | 水素化形態の縮合パラチノース | |
TW200410702A (en) | Agent for inhibiting rise in blood glucose level, agent for inhibiting body fat accumulation and edible material | |
CN112167639A (zh) | 一种双向调节晨起肠道液体平衡的组合物、制备方法及其用途 | |
EP1616873B1 (en) | Lipid-regulating agent and use thereof | |
KR100448009B1 (ko) | 생약추출물 함유 기능성 젤리의 제조 방법 및 그에 의해제조된 기능성 젤리 | |
US8148351B2 (en) | Enteropathy ameliorating composition | |
KR101721145B1 (ko) | L-카르니틴 구연산 마그네슘을 포함하는 배변촉진 겸용 다이어트용 식품 조성물 | |
CN111149908A (zh) | 一种复合蔬果压片糖果及其制备方法 | |
CN112641098A (zh) | 一种具有调理肠胃腹泻功能的阿拉伯胶组合物 | |
KR20060024766A (ko) | 혈중 저분자량질소함유화합물의 농도를 저감시키는질병개선용식품 | |
CN106255502A (zh) | 饱腹感持续剂以及使饱腹感持续的方法 | |
CN112617204A (zh) | 一种具有润肠通便功效的阿拉伯胶组合物 | |
CN111685332A (zh) | 一种具有减脂塑形美体功能的组合物及其制备方法 | |
CN110800893A (zh) | 无蔗糖降脂减肥消肉食清热健脾利湿降糖饮料及其制备方法 | |
CN111149907A (zh) | 一种蓝莓叶黄素酯压片糖果及其制备方法 | |
CN108685101A (zh) | 林蛙肽菊粉 | |
KR101275725B1 (ko) | 감미료 조성물 및 그 제조방법 | |
CN110801474A (zh) | 一种防治便秘的组合物及其用途 | |
Kuthiala et al. | Benefits of functional oligosaccharides (FOS) in treating functional bowel disorders (FBD) and low caloric substitutes for diabetics | |
KR101337114B1 (ko) | 기능성 스프 및 이의 제조방법 | |
CN115475177A (zh) | 血糖值升高抑制剂及含其的经口组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |